Mild Cognitive Impairment (MCI) clinical trials in California
44 active Mild Cognitive Impairment (MCI) trials with a site in California. Describe your situation to see which ones look like a fit.
- Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
- BID WM Digital Intervention in Aging
- Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
- Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
- Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment
- Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
- TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
- BID LTM Digital Intervention in Aging
- Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Effects of Accelerated rTMS on Cognitive Function
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- CogT pSOPT Intervention Study
- The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
- Effect of Daily Mixed Spice Consumption on Memory Function
- Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
- The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Enhancing Attention and Wellbeing Using Digital Therapeutics
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Predicting Pre-dementia
- Senicapoc in Alzheimer's Disease
- Wayfinding Intervention and Long-Term Memory
- TabCAT Brain Health Assessment in Primary Care
- FACE Phase II (a Stage II Trial)
- Biomarker Exploration in Aging, Cognition and Neurodegeneration
- Epileptic Hippocampus in Alzheimer's Disease
- SleepSMART for Veterans With Insomnia and Mild Cognitive Impairment
- Light and Sleep Fragmentation
- Navigating the Clinical Research Process for Mild Cognitive Impairment
- Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease
- Ultrasonic Debris Clearance to Promote Brain Resilience
- Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
- Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans
- AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment
- Alzheimer's Disease Neuroimaging Initiative 4
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- The Digital Memory Notebook
- A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- Brain Health Virtual Reality Study
- Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.